Pipeline

Disease Area (Target)

Disease Area

Target

Partner

Discovery

Optimization

IND Enabling

Phase 1

Immunology

TYK2 - Peripheral

Immunology (TYK2 - Peripheral)

Immunology

TYK2 - CNS

Immunology (TYK2 - CNS)

Immunology

RIPK2

Immunology (RIPK2)

Immunology

IL-4Rα

Immunology (IL-4Rα)

Undisclosed

Undisclosed

Undisclosed (Undisclosed)

Undisclosed

Undisclosed

Undisclosed (Undisclosed)

Undisclosed

Undisclosed

Undisclosed (Undisclosed)

Learn more about our portfolio, pipeline, and career opportunities.

Contact Us